Argenx Se ARGX
NASDAQ ARGX
$1,038.85 -14.61 (-1.39%)
As of: Sep 4, 2026 · 10:51 AM EDT

Argenx Se (ARGX) Operating Expenses (2016 - 2026)

Argenx Se's (ARGX) quarterly Operating Expenses came in at $2.9 billion in Q2 2026, up 276.7% YoY from $766.1 million in Q2 2025, and up 414.04% on a QoQ basis from -$919.0 million in Q1 2026.

Analysis

Argenx Se (ARGX) Operating Expenses (2016 - 2026) Analysis & Trends

Argenx Se (ARGX) has 11 years of Operating Expenses data on file, last reported at $2.9 billion in Q2 2026.

  • Quarterly Operating Expenses rose 276.7% year-over-year to $2.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.8 billion (up 260.18% YoY) and the FY2025 annual result came in at $3.2 billion, up 40.49% from the prior year.
  • Operating Expenses rose to $2.9 billion in Q2 2026, from -$919.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $2.9 billion in Q2 2026 to a low of -$954.5 million in Q4 2025.
  • A 5-year average of -$178.7 million and a median of -$401.8 million in 2023 frame the typical range for Operating Expenses.
  • Annual changes were most pronounced in 2023 — Operating Expenses plunged 87.65% — and 2026, when it surged 276.7%.
  • Tracing ARGX's Operating Expenses over 5 years: stood at -$296.5 million in 2022, then sank by 87.65% to -$556.5 million in 2023, then dropped by 18.28% to -$658.2 million in 2024, then sank by 45.03% to -$954.5 million in 2025, then surged by 402.34% to $2.9 billion in 2026.
  • The last three Operating Expenses figures came in at $2.9 billion (Q2 2026), -$919.0 million (Q1 2026), and -$954.5 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Vertex Pharmaceuticals 139.68 Bn 131.82 Bn 2.84 Bn 2.09 Bn
2 Regeneron Pharmaceuticals 85.68 Bn 77.68 Bn 3.93 Bn 3.00 Bn
3 Argenx Se 63.67 Bn 58.48 Bn 1.37 Bn -1.05 Bn
4 Moderna 57.02 Bn 51.88 Bn 52.00 Mn 960.00 Mn
5 Revolution Medicines 43.83 Bn 43.83 Bn - 505.13 Mn
6 BeOne Medicines 39.97 Bn 34.87 Bn 1.53 Bn 1.21 Bn
7 Alnylam Pharmaceuticals 35.23 Bn 31.93 Bn 992.69 Mn 1.06 Bn
8 Royalty Pharma 28.56 Bn 27.72 Bn - 541.02 Mn
9 Insmed 27.54 Bn 26.38 Bn 358.27 Mn 427.03 Mn
10 Incyte 25.49 Bn 20.95 Bn 1.57 Bn 976.14 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.05 Bn
Mar 31, 2026 -919.00 Mn
Dec 31, 2025 -954.54 Mn
Sep 30, 2025 -805.14 Mn
Jun 30, 2025 -766.13 Mn
Mar 31, 2025 -668.00 Mn
Dec 31, 2024 -658.18 Mn
Sep 30, 2024 -574.69 Mn
Jun 30, 2024 -534.89 Mn
Mar 31, 2024 -505.93 Mn
Dec 31, 2023 -556.46 Mn
Sep 30, 2023 -420.43 Mn
Jun 30, 2023 -383.13 Mn
Mar 31, 2023 -333.62 Mn
Dec 31, 2022 -296.55 Mn
Sep 30, 2022 -355.13 Mn
Jun 30, 2022 -259.73 Mn
Mar 31, 2022 -254.21 Mn
Dec 31, 2021 -264.60 Mn
Sep 30, 2021 -220.06 Mn